First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia

---

Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 21
• Basım Tarihi: 2021
• Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Anahtar Kelimeler: CLL, acalabrutinib, ibrutinib, chronic lymphocytic leukemia, Bruton tyrosine kinase
• İstanbul Üniversitesi Adresli: Evet